2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Classical hematology
1
Conditions
Sarcoma
37
Ovarian Neoplasms
15
Leiomyosarcoma
12
Liposarcoma
10
Neoplasms
7
Sarcoma, Ewing
4
Neoplasm Metastasis
4
Liposarcoma, Myxoid
4
Sarcoma, Synovial
3
Rhabdomyosarcoma
3
Histiocytoma, Malignant Fibrous
3
Breast Neoplasms
3
Solitary Fibrous Tumors
2
Sarcoma, Alveolar Soft Part
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neurofibrosarcoma
2
Neoplasms by Site
2
Mesothelioma, Malignant
2
Malignant mesenchymal tumor
2
Ichthyosis, X-Linked
2
Hemangiosarcoma
2
Hemangiopericytoma, Malignant
2
Fibrosarcoma
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Bone Neoplasms
2
Wilms Tumor
1
Uterine Neoplasms
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Interventions
olaparib
9
Carboplatin
3
talazoparib
1
pembrolizumab
1
liposomal doxorubicin
1
iniparib
1
Trabectedin
1
Surveys and Questionnaires
1
Secretin
1
Paclitaxel
1
Genotype
1
Genetic Counseling
1
Demography
1
Data Collection
1
Counseling
1
Cognitive Behavioral Therapy
1
Biopsy, Fine-Needle
1
ABT-767
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fanconi Anemia, Complementation Group D1
×
Trabectedin
×
Clear all
NCT01772979
2013-01-21
MITO15
Catholic University of the Sacred Heart
Phase 2
Unknown
100 enrolled